IRIS PubliCatt

Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan

Annunziata, S., Calcagni, M. L., Indovina, L., Rufini, V., Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan., <<EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING>>, 2017; (44): 2140-2141. [doi:10.1007/s00259-017-3819-9] [http://hdl.handle.net/10807/112559]

Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan.

Annunziata, Salvatore
Primo
;Calcagni, Maria Lucia
Secondo
;Indovina, Luca
Penultimo
;Rufini, Vittoria
Ultimo
2017

Abstract

Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan
2017
Inglese
Annunziata, S., Calcagni, M. L., Indovina, L., Rufini, V., Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan., <<EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING>>, 2017; (44): 2140-2141. [doi:10.1007/s00259-017-3819-9] [http://hdl.handle.net/10807/112559]
Articolo in rivista, Nota a sentenza
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/112559
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact